The debate over vaping has intensified with experts advocating for stricter controls on the sale and distribution of nicotine-based vapes. As public health concerns mount, Professor Anthony Milton has voiced strong opinions about the addictive nature of vaping products and the potential health risks they pose. This article explores the argument for making vapes available...
Cannabis consumption has long been a topic of interest and debate, particularly as legalisation efforts expand globally. While its immediate effects are well-documented, recent research has shifted focus to its long-term biological impacts, specifically epigenetic changes. A study published in Molecular Psychiatry delves into this area, examining how cannabis use may alter the human epigenome....
A recent surge of illnesses linked to mushroom edibles has raised significant concerns about the safety and regulation of these products. This issue centres around Amanita muscaria-infused gummies, known for their psychoactive effects, and other synthetic compounds found in these edibles. As more than 140 documented cases of sickness, including two suspected deaths, have been...
As cannabis use continues to grow, its implications for medical professionals, particularly in surgical settings, have become increasingly significant. Otolaryngologists, who frequently encounter patients using cannabis, must understand the complexities it introduces into patient care. This analysis explores the multifaceted considerations for treating individuals who use cannabis, emphasising the need for comprehensive strategies in surgical...
Cannabis use and its potential health risks have become a topic of increasing relevance as its legalisation and social acceptance grow. A pivotal study published in JAMA Otolaryngology–Head & Neck Surgery explores the potential link between cannabis use and head and neck cancer, drawing parallels with historical patterns seen in tobacco use and cancer. Historical...
The forthcoming book, “Epidemiology of Cannabis: Genotoxicity, Neurotoxicity, Epigenomics and Aging” by Professors Albert Reece and Gary Hulse, is not only a cornerstone in the study of cannabis-related health impacts, but a must have for any clinician, researcher or health-care practitioner. Set to release on March 1, 2025, this comprehensive volume explores four critical areas...
The recent decision by Australia’s Therapeutic Goods Administration (TGA) to allow psychiatrists to prescribe MDMA and psilocybin for certain mental health conditions has sparked both excitement and concern in the medical and research communities. While proponents hail it as a breakthrough for patients with treatment-resistant depression and PTSD, many experts warn that the move may...
On August 21, 2024, the Drug Enforcement Administration (DEA) will recognise National Fentanyl Prevention and Awareness Day, joining a chorus of voices dedicated to educating the public about the severe dangers of fentanyl poisoning from counterfeit pills and other illicit drugs. This day of awareness comes at a crucial time, as the United States continues...
In North Dakota, the debate over recreational marijuana reignites as the Secretary of State approves a measure for the November 5, 2024, ballot. Despite previous rejections in 2018 and 2022, supporters persist, sparking opposition from figures such as Patrick Finken of the Brighter Future Alliance. Critics like Dr. Joan Connell, a paediatrician, argue against the...
Alcohol Focus Scotland is hosting an online event on August 29th to launch a new literature review by the University of Nottingham, examining the impact of alcohol marketing on individuals with or at risk of alcohol problems. The event will feature presentations from researchers, insights from a person with lived experience, and contributions from the...